[1]
G. Tarro and D. Raiderman, “On the Treatment of a Patient with Ataxic Syndrome by Microdoses of Levo- and Carbo-Dopa. Post COVID Treatment”, BJHMR, vol. 9, no. 5, pp. 132–138, Oct. 2022.